Bupropion Extended-Release Tablets and Dihydroergotamine Mesylate
Determining the interaction of Bupropion Extended-Release Tablets and Dihydroergotamine Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Extended-Release Tablets-Dihydroergotamine nasal
- Bupropion Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Bupropion Extended-Release Tablets-Dilacor XR
- Bupropion Extended-Release Tablets-Dilantin
- Bupropion Extended-Release Tablets-Dilantin Infatabs
- Bupropion Extended-Release Tablets-Dilantin injection
- Dihydroergotamine Mesylate-Bupropion Hydrochloride
- Dihydroergotamine Mesylate-Bupropion SR Tablets
- Dihydroergotamine Mesylate-Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Dihydroergotamine Mesylate-Bupropion Tablets
- Dihydroergotamine Mesylate-Bupropion Tablets and Sustained-Release Tablets
- Dihydroergotamine Mesylate-Burapren Injection